Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002492 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002492 is a Phase 2 study that has completed, run by University of Miami.
The verdict
NCT00002492, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining cisplatin and doxorubicin in treating patients who have soft tissue sarcoma.
Interventions
- DRUG cisplatin
- PROCEDURE conventional surgery
- RADIATION brachytherapy
- DRUG doxorubicin hydrochloride
- DRUG isolated limb perfusion
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-11 |
| Est. Completion | 2000-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002492
The ClinicalTrials.gov registry entry for NCT00002492 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00002492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002492 about?
NCT00002492 is a clinical study titled "Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining cisplatin and doxorubicin in treating patients who have sof...
What is the current status of trial NCT00002492?
This trial is currently completed. It is a Phase 2 study. The study started on 1991-11. Estimated completion is 2000-02.
What interventions are being tested in trial NCT00002492?
The interventions under investigation include: cisplatin (DRUG), conventional surgery (PROCEDURE), brachytherapy (RADIATION), doxorubicin hydrochloride (DRUG), isolated limb perfusion (DRUG).
Who is sponsoring clinical trial NCT00002492?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.